Search results
Showing 7336 to 7350 of 7688 results
This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.
This evidence summary was produced at the start of the COVID-19 pandemic, when evidence was emerging. It has been withdrawn as the content is no longer relevant. See NICE's COVID-19 rapid guideline: managing COVID-19 for current guidance.
In development [GID-TA11441] Expected publication date: TBC
This medtech innovation briefing (MIB) has been replaced by NICE medical technologies guidance on Kurin Lock for blood culture collection.
In development [GID-TA11199] Expected publication date: TBC
BPMpathway for rehabilitation support in joint replacement surgery (MIB319)
MIB319 BPMpathway for rehabilitation support in joint replacement surgery has been withdrawn. This is because factual inaccuracies have been identified. NHS England no longer fund NICE to produce or maintain medtech innovation briefings, therefore these are no longer being reviewed.
Sodium phenylbutyrate–ursodoxicoltaurine for treating amyotrophic lateral sclerosis [ID6246]
In development [GID-TA11264] Expected publication date: TBC
Spesolimab for preventing generalised pustular psoriasis flares [ID6216]
In development [GID-TA11189] Expected publication date: TBC
In development [GID-TA11252] Expected publication date: TBC
Pemigatinib for treating myeloid or lymphoid neoplasms with a FGFR1 rearrangement [ID6172]
In development [GID-TA11109] Expected publication date: TBC
In development [GID-TA11033] Expected publication date: TBC
The IN.PACT drug-coated balloon for peripheral arterial disease (CANCELLED)
Discontinued [GID-MT517]
Empagliflozin for preventing cardiovascular events after acute myocardial infarction [ID6240]
In development [GID-TA11265] Expected publication date: TBC
In development [GID-TA11443] Expected publication date: TBC